HCID 178418361, compound → HCID 178441243, compound
Reaction equation
[CH2:1]([C:5]1[N:9]2[CH:10]([C:16]3[CH:21]=[CH:20][C:19]([C:22]4[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=4[C:28]4[NH:32][N:31]=[N:30][N:29]=4)=[CH:18][CH:17]=3)[CH2:11][CH2:12][C:13](=[N:14]O)[C:8]2=[N:7][CH:6]=1)[CH2:2][CH2:3][CH3:4].[H][H]>[Pd].CO>[CH2:1]([C:5]1[N:9]2[CH:10]([C:16]3[CH:17]=[CH:18][C:19]([C:22]4[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=4[C:28]4[NH:32][N:31]=[N:30][N:29]=4)=[CH:20][CH:21]=3)[CH2:11][CH2:12][CH:13]([NH2:14])[C:8]2=[N:7][CH:6]=1)[CH2:2][CH2:3][CH3:4]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
Alternatively, the title compound of Example 1451 can be prepared from the corresponding oxime. A suspension of the biphenyl imidazolyl oxime (0.059 mmol, the title compound of Example 1449) and 20 mg (0.0188 mmol) of 10% palladium on charcoal in 1.5 mL of methanol is stirred at room temperature under 50 psi of hydrogen gas until the reaction is complete. The mixture is filtered through a pad of celite, concentrated in vacuo and purified to give the title compound of Example 1451.
Workup
- filtrationThe mixture is filtered through a pad of celite
- concentrationconcentrated in vacuo
- custompurified
Sources & evidence
- ORD record
- ord-692fdb2f469d43c3bdee7f7f66134e3f
- Source dataset
- uspto-grants-1995_06
- Patent number
- US05426105
Reaction notes
Loading…